Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New immunosuppressive, anticancer compounds from Kyowa Hakko

Oct. 15, 1997

Resistance modulators prepared by Byk Gulden

Oct. 15, 1997

Mayo Clinic to collaborate in developing Dendreon's dendritic cell therapy

Oct. 15, 1997

ONYX-015 combination enters phase II; U.S. patent awarded

Oct. 15, 1997

St. Jude researchers discover new role for p53

Oct. 14, 1997

Pharmacia & Upjohn discloses new distamycin derivatives

Oct. 14, 1997

Antiproliferative activity of simvastatin demonstrated against human gliomas

Oct. 13, 1997

Improved efficacy of MEN-10755 related to apoptosis?

Oct. 13, 1997

DUROS leuprolide enters phase III for prostate cancer

Oct. 10, 1997

Demeter BioTechnologies awarded grant for cancer therapeutics program

Oct. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...